Central toxic keratopathy (CTK) describes a rare, acute, non-inflammatory complication most associated with excimer laser ablation surgery (e.g., laser assisted in situ keratomileusis (LASIK) or photorefractive keratopathy (PTK) surgery).

Aug 8, 2023 · Central toxic keratopathy (CTK), first described in 1998, has numerous alternative descriptive names including stage IV diffuse lamellar keratitis, central lamellar keratitis, central flap necrosis, central necrosis lamellar inflammation, and …

Nov 22, 2023 · The central toxic keratopathy (CTK) syndrome is an uncommon, acute, non-inflammatory condition that, following refractive surgery, causes widespread opacification of the center corneal stroma.

May 14, 2020 · While central opacification and edema associated with the conditions can be similar, CTK eyes are white and quiet. There is no injection nor an anterior chamber reaction that often accompanies infectious keratitis.

The Central Toxic Keratopathy (CTK) syndrome describes a rare, acute, self-limited, non-inflammatory process that yields central corneal opacification and significant hyperopic shift after refractive surgery.

Oct 18, 2023 · Learn about central toxic keratopathy (CTK), a rare corneal disorder linked to toxic ophthalmic medications. Understand its causes, symptoms, diagnosis, treatment options, and management strategies for better visual outcomes.

People who develop Central Toxic Keratopathy (CTK) might first experience symptoms associated with Diffuse Lamellar Keratitis (DLK), another condition that can happen after certain eye laser surgeries.

Mar 1, 2023 · Corneal collagen cross-linking (CXL) is a revolutionary procedure to halt keratoconus (KCN) progression, but it is not complication-free. Infectious keratitis, persistent epithelial defects, corneal edema, or severe melt have been reported after CXL (1).

Purpose of review: To describe recent evidence from the literature regarding central toxic keratopathy syndrome (CTK). Recent findings: CTK describes a rare, self-limited, noninflammatory postsurgical condition that presents with central corneal opacity and …

May 28, 2020 · SMILE is considered an alternative to conventional laser in situ keratomileusis because of its benefits of reduced denervation, less postoperative dry eye, and no flap-related complications . To the best of our knowledge, we report the …